T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Huntington Ingalls Industries
HII
$12.8B
| $11.5M | ﹤0.01% |
61,032
-566,563
| -90% | -$122M |
|
1127
Advanced Drainage Systems
WMS
$11.3B
| $11.5M | ﹤0.01% |
99,401
-28,077
| -22% | -$3.9M |
|
|
APLS
1128
DELISTED
Apellis Pharmaceuticals
APLS
| $11.4M | ﹤0.01% |
358,578
-19,878
| -5% | -$598K |
|
|
BBOT
1129
BridgeBio Oncology
BBOT
$740M
| $11.4M | ﹤0.01% |
1,087,771
-39,827
| -4% | -$419K |
|
1130
Hyatt Hotels
H
$16.9B
| $11.4M | ﹤0.01% |
72,651
+2,509
| +4% | +$389K |
|
1131
Acadia Pharmaceuticals
ACAD
$4.89B
| $11.4M | ﹤0.01% |
621,010
-38,954
| -6% | -$629K |
|
1132
Check Point Software Technologies
CHKP
$13.7B
| $11.4M | ﹤0.01% |
60,861
+6,620
| +12% | +$1.25M |
|
1133
Columbia Banking Systems
COLB
$9.18B
| $10.8M | ﹤0.01% |
398,482
+283,643
| +247% | +$8.13M |
|
1134
Inspire Medical Systems
INSP
$1.68B
| $10.7M | ﹤0.01% |
57,932
-106,173
| -65% | -$20.6M |
|
|
PRMB
1135
Primo Brands
PRMB
$8.97B
| $10.6M | ﹤0.01% |
+345,738
| New | +$10.2M |
|
1136
Choice Hotels
CHH
$4.71B
| $10.6M | ﹤0.01% |
74,842
-144,595
| -66% | -$20.5M |
|
1137
DaVita
DVA
$11.4B
| $10.5M | ﹤0.01% |
70,424
-4,880
| -6% | -$765K |
|
1138
Magnolia Oil & Gas
MGY
$6.13B
| $10.5M | ﹤0.01% |
449,540
-84,568
| -16% | -$2.2M |
|
1139
Hasbro
HAS
$13.6B
| $10.5M | ﹤0.01% |
187,871
-1,969
| -1% | -$128K |
|
1140
Oric Pharmaceuticals
ORIC
$1.42B
| $10.5M | ﹤0.01% |
1,295,025
+180,140
| +16% | +$1.65M |
|
1141
BorgWarner
BWA
$13.8B
| $10.3M | ﹤0.01% |
325,228
-220
| -0.1% | -$7.49K |
|
1142
HEICO Corp Class A
HEI.A
$38.1B
| $10.3M | ﹤0.01% |
55,131
+3,258
| +6% | +$657K |
|
1143
CONMED
CNMD
$1.49B
| $10.2M | ﹤0.01% |
149,670
+3,260
| +2% | +$227K |
|
1144
SAP
SAP
$242B
| $10.2M | ﹤0.01% |
41,493
-24,885
| -37% | -$5.92M |
|
1145
Hims & Hers Health
HIMS
$6.71B
| $10.2M | ﹤0.01% |
420,348
+312,908
| +291% | +$7.75M |
|
1146
Fidelity National Financial
FNF
$13.1B
| $10.1M | ﹤0.01% |
180,293
-6,594
| -4% | -$397K |
|
1147
Jones Lang LaSalle
JLL
$17B
| $10.1M | ﹤0.01% |
39,940
+36
| +0.1% | +$9.59K |
|
1148
Caesars Entertainment
CZR
$6.04B
| $10.1M | ﹤0.01% |
302,482
-265
| -0.1% | -$10.5K |
|
1149
Brixmor Property Group
BRX
$9.21B
| $10.1M | ﹤0.01% |
362,770
+56,095
| +18% | +$1.59M |
|
1150
Moog Inc Class A
MOG.A
$13.5B
| $9.97M | ﹤0.01% |
50,648
-10,512
| -17% | -$2.16M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.